SCHEMBL30962660

SCHEMBL30962660

COc1nc(Nc2ccc(C3CCN(C(=O)OC(C)(C)C)C3)c(C)c2)ncc1C(=O)Nc1c(Cl)cccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.44
▸ MAPT P10636 5/20 0.41
▸ JAK3 P52333 2/20 0.40
▸ PTK2 Q05397 2/20 0.40
▸ SRC P12931 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ CCNK O75909 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ CCND3 P30281 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ CDK6 Q00534 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ GPR35 Q9HC97 1/20 0.39
▸ GPR55 Q9Y2T6 1/20 0.39
▸ TP53 P04637 3/20 0.39
▸ SIK1 P57059 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962866 1.00 IGF1R (0.44) IGF1RMAPTJAK3PTK2SRC
SCHEMBL30962735 1.00 IGF1R (0.44) IGF1RMAPTJAK3PTK2SRC
SCHEMBL30962691 0.97 IGF1R (0.42) IGF1RMAPTJAK3PTK2SRC
SCHEMBL30962722 0.97 IGF1R (0.42) IGF1RMAPTJAK3PTK2SRC
SCHEMBL30962726 0.97 IGF1R (0.42) IGF1RMAPTJAK3PTK2SRC
SCHEMBL30962749 0.89 PIK3CD (0.43) IGF1RSRCCCNKCCNA2CDK2
SCHEMBL30962935 0.88 WEE1 (0.46) JAK3PTK2SRCSIK1SIK2
SCHEMBL30962635 0.88 WEE1 (0.46) JAK3PTK2SRCSIK1SIK2
SCHEMBL30962914 0.88 WEE1 (0.46) JAK3PTK2SRCSIK1SIK2
SCHEMBL30962752 0.88 MAPT (0.43) IGF1RMAPTJAK3PTK2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback